Beta Bionics, Inc.
Caution: The iLet Bionic Pancreas is an investigational instrumentality constricted by Federal instrumentality to investigational use. Not disposable for sale.
Steven Russell
Steven Russell
CONCORD, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. — a clinical-stage aesculapian exertion institution — announced the assignment of Steven Russell, MD, Ph.D., to the relation of Chief Medical Officer arsenic the institution prepares for the commercialized motorboat of the iLet Bionic Pancreas System.
"As we determination person to commercialized motorboat of the iLet Bionic Pancreas, we person strategically added a wealthiness of cognition and acquisition to our enforcement team," explained Sean Saint, President and CEO of Beta Bionics. "Dr. Russell is 1 of the foremost thought leaders successful the tract of diabetes technology, and I person turned to him often implicit the years for his expertise and perspective. His acquisition with the bionic pancreas successful a objective mounting is 2nd to none. There is nary amended idiosyncratic we could person for our Chief Medical Officer arsenic we implicit the regulatory reappraisal process and hole for the U.S. motorboat of the iLet."
Dr. Russell is an endocrinologist and diabetologist with 20 years of acquisition managing diabetes. He is an Associate Professor of Medicine astatine Harvard Medical School and an attending doc at Massachusetts General Hospital (MGH) Diabetes Associates successful Boston, wherever helium has maintained a objective practice managing diabetes successful the outpatient and inpatient settings. Dr. Russell's probe astatine MGH has been focused on the exertion of caller technologies to amended the attraction of radical with diabetes, including the collaboration with Dr. Ed Damiano's probe radical astatine Boston University to make and trial a wearable bionic pancreas for automated humor glucose power successful diabetes. Dr. Russell has directed astir each of the bionic pancreas objective trials, including 20 studies successful benignant 1 diabetes, benignant 2 diabetes, and cystic fibrosis-related diabetes. He received a Bachelor of Science grade successful biochemistry from Trinity University successful San Antonio, and some a Ph.D. successful biologic chemistry and an MD from the University of Texas Southwestern Medical Center successful Dallas. He completed his residency grooming successful interior medicine and his fellowship successful endocrinology, diabetes, & metabolism astatine MGH, and a postdoctoral fellowship studying insulin and aging astatine the Joslin Diabetes Center successful Boston.
"The bionic pancreas task has been the absorption of my nonrecreational beingness for galore years. Until the completion of the pivotal trial, I felt I was capable to bring the astir worth to the task arsenic an world physician, providing proposal and executing objective trials," said Dr. Russell. "Now that the pivotal proceedings is complete, I deliberation my contributions volition beryllium astir impactful by providing aesculapian enactment wrong Beta Bionics arsenic we enactment to get FDA clearance and hole for the motorboat of the iLet. I americium excited to beryllium portion of an all-star squad and look guardant to supporting radical with diabetes and healthcare providers arsenic the iLet emerges from the probe mounting into objective use."
The iLet is simply a pocket-sized, wearable investigational aesculapian instrumentality designed to autonomously dose insulin. It is designed to beryllium worn similar an insulin pump, but iLet users participate lone their assemblage value to initialize therapy and bash not acceptable immoderate insulin regimen parameters. The iLet is designed to past automatically titrate and infuse insulin without requiring the idiosyncratic to number carbohydrates, acceptable insulin-to-carbohydrate ratios, acceptable insulin basal rates, acceptable correction factors, oregon find bolus insulin for meals oregon corrections. The exertion is designed to assistance a wide basal of radical who privation to usage exertion to negociate diabetes.
"I americium thrilled to invited Steven to Beta Bionics arsenic our caller Chief Medical Officer," said Ed Damiano, Ph.D., Founder and Executive Chair of Beta Bionics. "I began collaborating with Steven connected the bionic pancreas task implicit 15 years ago. Our concern has spanned inpatient objective trials, pre-pivotal home-use objective trials, and astir recently, a pivotal proceedings of the iLet successful adults and children with benignant 1 diabetes. Simply put, the bionic pancreas would not beryllium arsenic acold on arsenic it is contiguous without Steven Russell. As a genitor of a lad with T1D, I americium grateful for each that helium has done to beforehand this exertion and advocator for each radical with T1D."
Dr. Russell volition clasp his Harvard Medical School module assignment and volition support his aesculapian signifier connected a part-time ground astatine MGH Diabetes Associates.
Caution: The iLet Bionic Pancreas is an investigational device, pending 510(k) clearance. Not disposable for sale.
Related Images
This contented was issued done the press merchandise organisation work astatine Newswire.com.
Attachment
English (US)